Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

In April 2025, the U.S. Food and Drug Administration (FDA) approved Teva's digital inhaler, which combines built-in sensors with a companion mobile app to assist in managing asthma and COPD symptoms.

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... with asthma and COPD under a 510 ...

In addition to cigarette smoke, cigar smoke, pipe smoke, and secondhand smoke can cause COPD. Your risk of COPD is even greater if you have asthma and ... taken through an inhaler or nebulizer.

Background: The proliferation of inhaler devices has resulted in a ... When selecting an aerosol delivery device for patients with asthma and COPD, the following should be considered: device ...

Report Ocean has published a new report on the Saudi Arabia Respiratory Devices Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The ...

More children stopped using steroid inhalers to control their asthma after GlaxoSmithKline withdrew Flovent from the market.

Economic uncertainty following tariffs could change Sarasota, Manatee real estate market Embattled Michigan Gov. Gretchen ...

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a ...